Pharvaris (NASDAQ:PHVS) Receives $36.20 Consensus Target Price from Analysts
Shares of Pharvaris (NASDAQ:PHVS – Get Free Report) have received an average recommendation of “Buy” from the five ratings firms that are presently covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock in the last […]
Shares of Pharvaris (NASDAQ:PHVS – Get Free Report) have received an average recommendation of “Buy” from the five ratings firms that are presently covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have covered the stock in the last […]
